AMT-130
Gene Therapy Breakthrough Slows Huntington’s Disease Progression by 75%
A pioneering gene therapy, AMT-130, is the first to significantly slow Huntington’s disease, marking a historic advance for patients and families.
A pioneering gene therapy, AMT-130, is the first to significantly slow Huntington’s disease, marking a historic advance for patients and families.